Skip to content

Clinical trials

Rare Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rare Diseases Country / region: France Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20063
20091
20102
20132
20141
20153
20162
20173
20182
20193
20203
20215
20224
20236
20246
20254
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting21
Unknown status6
Terminated3
Not yet recruiting3
Withdrawn2
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris10
Institut National de la Santé Et de la Recherche Médicale, France7
Imagine Institute6
Amgen3
Assistance Publique Hopitaux De Marseille2
Associazione Angela Serra per la ricerca sul cancro2
Centre Hospitalier Universitaire Dijon2
Hospices Civils de Lyon2
Laboratoire français de Fractionnement et de Biotechnologies2
Novartis Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rare Diseases59
Intellectual Disability5
Genetic Diseases, Inborn4
Metabolic Diseases4
Cystinosis3
Neurodegenerative Diseases3
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating3
Arthritis, Juvenile2
Autism Spectrum Disorder2
Autoimmune Diseases2

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.